Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 4 | — | — |
HiB 1/19/1995; HiB 12/16/1993; This spontaneous report has been received from a lawyer, via an immunization record from a case in litigation for Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (case # 2249323), concerning a 5-month-old female patient. Concurrent condition and medical history were not reported. Concomitant vaccine included diphtheria vaccine toxoid (+) pertussis vaccine (+) tetanus vaccine toxoid (DTP). On 21-OCT-1993, the patient was vaccinated with the 1st dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) suspension for injection, administered for prophylaxis at a hospital (strength, dose, route, lot#, and expiration date were not reported). On 16-DEC-1993, the patient was vaccinated with the 2nd dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (Inappropriate schedule of product administration). On 18-JUL-1994, the patient was vaccinated with the 3rd dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown). On 19-JAN-1995, the patient was vaccinated with the 4th dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (Extra dose administered). This is one of several reports for the same patient.